Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $901M | $1.09B | $1.19B | $1.24B |
| Revenue growth | — | 21.3% | 8.7% | 4.3% |
| Gross profit | $749M | $919M | $957M | $994M |
| Gross margin | 83.1% | 84.1% | 80.6% | 80.2% |
| Operating income | -$81.0M | -$152M | $38.0M | $262M |
| Operating margin | -9.0% | -13.9% | 3.2% | 21.1% |
| Net income | -$44.0M | -$126M | $7.00M | $210M |
| Net margin | -4.9% | -11.5% | 0.6% | 16.9% |
| EPS (diluted) | -$0.32 | -$0.92 | $0.05 | $1.64 |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | -$4.00M | -$300M | $36.0M | -$27.0M |
| Capital expenditures | $5.00M | $8.00M | $29.0M | $66.0M |
| Free cash flow | -$9.00M | -$308M | $7.00M | -$93.0M |
| Share buybacks | $90.0M | $33.0M | $173M | $11.0M |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | $774M | $316M | $319M | $195M |
| Total assets | — | $1.76B | $1.32B | $1.20B |
| Total liabilities | — | $1.94B | $1.65B | $1.30B |
| Long-term debt | — | $237M | $315M | $290M |
| Shareholders' equity | -$15.0M | -$184M | -$337M | -$98.0M |
| Retained earnings | — | -$288M | -$443M | -$243M |
| Shares (wtd avg diluted) | 139M | 137M | 133M | 128M |
Every figure is extracted from Indivior Pharmaceuticals, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.